AQW-11882-98937
4 vaccinations
7 coded responses
36 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · HeadacheFree text: Swollen lymph node above left clavicleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · HeadacheFree text: Lymph node still swollen (above left clavicle)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Headache, Fatigue or tirednessFree text: Swollen lymph nodes - left armpit & above left clavicleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Headache, Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: ColdMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
-
2021-10-25
Survey response — day 21, dose 3MedDRA: Salivary gland pain, Sensory disturbance — Feeling: GoodFree text: Episodes of "wetness" sensation in back of left thigh, though there was not anything wet on the surface of my skin. This happened over the course of 2 -3 days last week. I also had some mild pain in my right salivary gland when eating on 2 days.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-04
- 2022-04-04
-
2022-10-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-04
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2023-01-02
-
2023-04-03
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-03
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-03 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node above left clavicle
Systemic reaction (other): Lymph node still swollen (above left clavicle)
Systemic reaction (other): Swollen lymph nodes - left armpit & above left clavicle
Systemic reaction (other): Swollen lymph nodes
Release 9 — 6 months, dose 2
Symptoms: Cold
Release 10 — day 21, dose 3
Symptoms: Episodes of "wetness" sensation in back of left thigh, though there was not anything wet on the surface of my skin. This happened over the course of 2 -3 days last week. I also had some mild pain in my right salivary gland when eating on 2 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Salivary gland pain | · | · | ✓ |
| SD | Sensory disturbance | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release